The iconic rise of Viagra has long been a symbol of pharmaceutical success, yet its legacy within the broader sector now triggers questions about long-term yields . Generic versions are eroding exclusivity , leading to anxieties that supporting companies heavily reliant to Viagra's previous position could be a speculative strategy, especially given